Cargando…
COVID-19 Antibody Response in Patients with Thalassemia
Background The coronavirus disease 2019 (COVID-19) can severely affect people with comorbidities such as those with diabetes, hypertension, chronic lung disease, cancer, and hemoglobinopathies. Studies assessing the clinical characteristics and immune response to COVID-19 infection in patients with...
Autores principales: | Kumari, Nidhi, Gomber, Sunil, Dewan, Pooja, Narang, Shiva, Ahmed, Rafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351617/ https://www.ncbi.nlm.nih.gov/pubmed/37465812 http://dx.doi.org/10.7759/cureus.40567 |
Ejemplares similares
-
SARS-CoV-2 antibody response in transfusion-dependent thalassemia
por: Kumari, Nidhi, et al.
Publicado: (2021) -
Effect of COVID-19 on Stress and Biomarkers: An Exploratory Cross-Sectional Study
por: Kumari, Amita, et al.
Publicado: (2023) -
Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study
por: Kanokudom, Sitthichai, et al.
Publicado: (2023) -
COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
por: Ammar, Ali, et al.
Publicado: (2022) -
Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19
por: Prakash, Om, et al.
Publicado: (2021)